Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Inflammatory Beard Alopecia

Description

The discussion focuses on inflammatory beard alopecia, presenting cases that highlight diagnostic and treatment challenges in men. The first case features a 25-year-old patient with persistent pustules and subsequent permanent hair loss in the beard area, initially misdiagnosed as acne. A biopsy revealed lymphocytic scarring alopecia, leading to a diagnosis of beard localized lichen planopilaris (LPP), which is rare in younger men without scalp involvement. Treatment with topical ruxolitinib proved effective but required strict adherence to avoid flaring. The second case involves a 27-year-old with recurrent pustules post-imiquimod treatment. Diagnosed with folliculitis decalvans, the case emphasized the importance of cultures and biopsy in ensuring accurate diagnosis and management. After multiple treatments, including antibiotics with limited success, the patient was treated with diclofenac sodium gel, showing promise as it addresses inflammatory responses in the hair follicle. The session also briefly touched upon infectious causes of pustules in the beard area, underscoring the need for thorough investigations. The overarching message stresses the psychological significance of beard health in men and the necessity for tailored treatments that effectively address these conditions.

View more

Conclusions

  • Beard alopecia can be a manifestation of rare conditions such as lichen planopilaris (LPP) and folliculitis decalvans, particularly in men.
  • Initial misdiagnosis as acne is common in cases of pustules and bumps in the beard area, highlighting the importance of appropriate diagnostic evaluations.
  • LPP in the beard is exceedingly rare and most commonly occurs in middle-aged men with significant scalp involvement, which was not present in the studied cases.
  • Effective treatment strategies for beard alopecia may include topical ruxolitinib, especially for conditions like beard LPP.
  • Patients with folliculitis decalvans may experience recurring symptoms despite various treatments, thus necessitating a tailored therapeutic approach, including potential use of systemic antibiotics or topical therapies.
  • Patch testing for allergic reactions should be considered in patients with unexplained or refractory beard alopecia, particularly in cases associated with frontal fibrosing alopecia (FFA).
  • Early and aggressive treatment is critical in managing scarring alopecias in the beard, given the psychological importance of facial hair for many men.
  • Infections are a common differential diagnosis and should always be excluded during the evaluation of pseudofolliculitis or pustules in the beard area.
  • Skin Appendage Disord. 2016 Sep; 2(1-2): 72-75
  • Senna MM et al. A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States. J Am Acad Dermatol. 2023 Apr;88(4):937-939
  • Senatore S, et al. Folliculitis decalvans with exclusive beard involvement. Indian Journal of Dermatology, Venereology and Leprology
  • Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi-center study. DERMATOLOGIC WILEY.